Ticagrelor (Brilinta)

Platelet aggregation inhibitor (P2Y12 receptor antagonist)

Ticagrelor (Brilinta)

Forms and strengths
Form: TabletStrength: 60 mg, 90 mg
Print

Indication

  • Ticagrelor, combined with low-dose aspirin, is used to reduce the risk of further heart attack, stroke, or cardiovascular death in patients who have had acute coronary syndrome.
  • Ticagrelor, combined with low-dose aspirin, is used for long-term secondary prevention in patients with a history of heart attack at least one year earlier who remain at high risk.
  • Ticagrelor, combined with low-dose aspirin, is used to reduce the risk of a first heart attack or stroke in patients with coronary artery disease, type 2 diabetes, and a history of a coronary artery procedure (percutaneous coronary intervention).

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.